Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 710 (USA) (Dr. Silva)
· consented 2012-09-26
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-29 (study day 126.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate COUGH — outcome: RECOVERED/RESOLVED; onset 2012-11-22 (study day 58.0); relationship: NONE
mild
assessed
2026-08-18
Mild SHOULDER PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-13 (study day 110.0); relationship: NONE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.